Compile Data Set for Download or QSAR
Report error Found 91 Enz. Inhib. hit(s) with Target = 'CB1 cannabinoid receptor-interacting protein 1'
TargetCB1 cannabinoid receptor-interacting protein 1(Duck leech)
State University of New York At Old Westbury

Curated by PDSP Ki Database
LigandPNGBDBM22988(Arachidonoyl ethanolamide | Arachidonoylethanolami...)
Affinity DataKi:  33.3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2012
Entry Details Article
PubMed
TargetCB1 cannabinoid receptor-interacting protein 1(Duck leech)
State University of New York At Old Westbury

Curated by PDSP Ki Database
LigandPNGBDBM21244(CP-56667 [(+)-AC],XV | CP-55,940 | 2-[(1S,2S,5S)-5...)
Affinity DataKi:  33.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2012
Entry Details Article
PubMed
TargetCB1 cannabinoid receptor-interacting protein 1(Duck leech)
State University of New York At Old Westbury

Curated by PDSP Ki Database
LigandPNGBDBM21278(SR141716 | 5-(4-chlorophenyl)-1-(2,4-dichloropheny...)
Affinity DataKi:  34.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2012
Entry Details Article
PubMed
TargetCB1 cannabinoid receptor-interacting protein 1(Duck leech)
State University of New York At Old Westbury

Curated by PDSP Ki Database
LigandPNGBDBM21281(WIN55212-2 | CHEMBL188 | (2,3-dihydro-5-methyl-3-(...)
Affinity DataKi:  58.6nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2012
Entry Details Article
PubMed
TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762777(US20250248973, Compound 65)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762753(US20250248973, Compound 9)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762754(US20250248973, Compound 11)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762755(US20250248973, Compound 13)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762749(US20250248973, Compound 1)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762798(US20250248973, Compound 143)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762751(US20250248973, Compound 5)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762808(US20250248973, Compound 163)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762761(US20250248973, Compound 26)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762809(US20250248973, Compound 165)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM646494(US20240024403, Compound Albanin)
Affinity DataIC50: 100nMAssay Description:The CB1 binding assay, described in Example 2, was used to test the Kuwanon G and Albanin G compounds isolated and identified in Example 5. The Kuwan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762762(US20250248973, Compound 27)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762810(US20250248973, Compound 167)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762763(US20250248973, Compound 29)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762811(US20250248973, Compound 169)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762756(US20250248973, Compound 14)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762804(US20250248973, Compound 155)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762757(US20250248973, Compound 17)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762805(US20250248973, Compound 157)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762758(US20250248973, Compound 18)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762806(US20250248973, Compound 159)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762759(US20250248973, Compound 21)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762768(US20250248973, Compound 45)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762816(US20250248973, Compound 191)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762769(US20250248973, Compound 47)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762770(US20250248973, Compound 48)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762786(US20250248973, Compound 115)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762764(US20250248973, Compound 31)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762772(US20250248973, Compound 53)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762813(US20250248973, Compound 183)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762766(US20250248973, Compound 35)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762767(US20250248973, Compound 43)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762773(US20250248973, Compound 54)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762792(US20250248973, Compound 127)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762824(US20250248973, Compound 247)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762776(US20250248973, Compound 61)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762820(US20250248973, Compound 235)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762789(US20250248973, Compound 122)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762781(US20250248973, Compound 87)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762821(US20250248973, Compound 239)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762822(US20250248973, Compound 241)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762791(US20250248973, Compound 125)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762823(US20250248973, Compound 245)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762752(US20250248973, Compound 6)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762800(US20250248973, Compound 147)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762801(US20250248973, Compound 149)
Affinity DataIC50: 300nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: